MARKET

CLVLF

CLVLF

Clinuvel Pharma
OTCPK
5.05
-0.10
-1.94%
Closed 09:45 10/23 EDT
OPEN
5.05
PREV CLOSE
5.15
HIGH
5.05
LOW
5.05
VOLUME
100
TURNOVER
505
52 WEEK HIGH
8.27
52 WEEK LOW
5.05
MARKET CAP
254.96M
P/E (TTM)
10.93
1D
5D
1M
3M
1Y
5Y
1D
Analysts Have Conflicting Sentiments on These Healthcare Companies: Clinuvel Pharmaceuticals (OtherCLVLF) and Telix Pharmaceuticals (OtherTLPPF)
TipRanks · 4d ago
Clinuvel Pharmaceuticals Reports Cessation of Securities in October 6-K Filing
TipRanks · 10/15 10:32
Clinuvel Pharmaceuticals Updates U.S. Investors on New and Ceased Securities via Form 6-K
TipRanks · 10/07 10:28
Clinuvel Pharmaceuticals Reports Expiry of 61,272 Performance Rights
TipRanks · 10/05 22:10
Clinuvel urges stability ahead of AGM as board warns against potential spill
TipRanks · 10/01 23:29
Clinuvel Shows Sustained Vitiligo Repigmentation with SCENESSE Combo Therapy
TipRanks · 10/01 02:19
Clinuvel Unveils ZEROKIN Single-Use Device for Controlled-Release Drug Delivery
TipRanks · 09/09 10:49
Clinuvel Unveils ZEROKIN Device to Target Growing Self-Injection Market
TipRanks · 09/07 23:53
More
About CLVLF
Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.

Webull offers Clinuvel Pharmaceuticals Ltd stock information, including OTCPK: CLVLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLVLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLVLF stock methods without spending real money on the virtual paper trading platform.